1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
AssigneeMERZ PHARMA GmbH & CO. KGaA
InventorHjalmar KURZEN
Life of this patent
Estimating the term…
Abstract
The present invention relates to the treatment of an individual afflicted with mast cell mediated diseases comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative.
Claims14
A method of treating or preventing mast cell mediated diseases in a subject in need thereof, comprising administering an effective amount of a 1-amino-alkylcyclohexane derivative selected from neramexane and pharmaceutically acceptable salts thereof.
A pharmaceutical composition comprising a therapeutically effective amount of a 1-amino-alkylcyclohexane derivative selected from neramexane and pharmaceutically acceptable salts thereof, in combination with an additional pharmaceutical agent which has been shown to be effective for the treatment or the prevention of mast cell mediated diseases and, optionally, at least one pharmaceutically acceptable carrier or excipient.
Dependencies are inferred from the claim text.